FY2028 EPS Forecast for HealthEquity Decreased by Analyst

HealthEquity, Inc. (NASDAQ:HQY) – Analysts at Zacks Research decreased their FY2028 EPS estimates for HealthEquity in a research note issued on Tuesday, April 15th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $4.62 for the year, down from their prior forecast of $4.65. The consensus estimate for HealthEquity’s current full-year earnings is $2.32 per share.

A number of other research analysts have also issued reports on HQY. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and reduced their price objective for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. KeyCorp reduced their price target on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Wednesday. Wells Fargo & Company increased their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Barrington Research reissued an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. Finally, The Goldman Sachs Group decreased their target price on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday, March 27th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Buy” and an average price target of $111.75.

HealthEquity Stock Down 0.7 %

NASDAQ:HQY opened at $82.49 on Wednesday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock has a 50 day moving average of $95.89 and a 200-day moving average of $96.26. The firm has a market capitalization of $7.14 billion, a PE ratio of 75.68, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity has a 52 week low of $65.01 and a 52 week high of $115.59.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares of the company’s stock, valued at $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Several large investors have recently modified their holdings of the stock. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the fourth quarter worth approximately $26,000. Versant Capital Management Inc acquired a new position in HealthEquity in the 1st quarter worth approximately $28,000. Transce3nd LLC purchased a new position in HealthEquity during the 4th quarter worth approximately $29,000. Smartleaf Asset Management LLC grew its position in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares in the last quarter. Finally, Proficio Capital Partners LLC acquired a new stake in HealthEquity during the 4th quarter valued at $39,000. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.